Home Newsfeeds AC Immune Awarded New Grants From MJFF, Target ALS Supporting Programs Targeting TDP-43

AC Immune Awarded New Grants From MJFF, Target ALS Supporting Programs Targeting TDP-43

The Michael J. Fox Foundation grant supports the development of AC Immune's first-in-class TDP-43 PET tracer program Target ALS Foundation grant supports collaboration between AC Immune and world-class

byBenzinga Newsdesk

February 7, 2023

1 minute read

The Michael J. Fox Foundation grant supports the development of AC Immune’s first-in-class TDP-43 PET tracer program
- Target ALS Foundation grant supports collaboration between AC Immune and world-class institutions to accelerate the development of novel biofluid assays for detecting TDP-43-related neuropathologyA

Blackbaud Makes $5M Strategic Investment In UBIQ Education, To Allow K-12 Private Schools To Create Digital-First Experiences To Modernize The Admissions Process

By Benzinga Newsdesk

May 8, 9:05 AM

Partnership Will Enable K-12 Private Schools to Create Digital-First Experiences to Modernize the Admissions ProcessCHARLESTON, S.C., May 8, 2024 /PRNewswire/ -- Blackbaud (NASDAQ:BLKB), the leading provider of

BLKB

Goldman Sachs Upgrades Take-Two Interactive to Buy, Raises Price Target to $165

By Benzinga Newsdesk

October 6, 5:01 AM

Goldman Sachs analyst Eric Sheridan upgrades Take-Two Interactive (NASDAQ:TTWO) from Neutral to Buy and raises the price target from $131 to $165.

TTWO

$100 Invested In Illinois Tool Works 10 Years Ago Would Be Worth This Much Today

By Benzinga Insights

July 14, 12:46 PM

Illinois Tool Works (NYSE:ITW) has outperformed the market over the past 10 years by 2.18% on an annualized basis producing an average annual return of 12.76%. Currently, Illinois Tool Works has a market capitalization of $54.57 billion.

ITW